Potent Blend Of Treatments Combats Breast Tumors

At the conclusion of the decade old, coast-to-coast survey on women having a rare type of breast cancer, Richard J. Barth Jr., M.D., and three associate researchers are composing the case for a particular blend of treatments for halting the tumors prior to metastasis.

In the Aug-09 edition of the Annals of Surgical Oncology, Barth, an associate professor of surgery at Dartmouth Medical School (DMS) and his associates along with Wendy Wells, M.D. – a professor of pathology in DMS suggest employing adjunct radiotherapy on those patients that underwent breast-preservation surgery for controlling borderline malignant and malignant phyllodes tumors.

The follow-ups done on the improvement in 46 women that were given follow-up radiotherapy in thirty diverse organizations in eighteen states, the research group found that none of them showed any development of new-fangled tumors in the spots where the surgeons conducted margin-negative resection.

Amongst approximately five hundred women globally that were detected with the condition annually and underwent solely the surgery, the researchers stated that there was recession of tumors in 24% of patients having borderline malignant tumors and 20% of those women having malignant tumors.

Barth is the section head of general surgery at Dartmouth-Hitchcock Medical Center or DHMC, and Wells is the breast pathologist at DHMC wherein there were thirteen women that were candidates in the study.

Popularity: 5% [?]